Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.94K Buy
37
+4
+12% +$484 ﹤0.01% 355
2026
Q1
$5.4K Buy
33
+15
+83% +$2.31K ﹤0.01% 326
2025
Q4
$3.13K Buy
18
+8
+80% +$1.46K ﹤0.01% 328
2025
Q3
$1.44K Buy
+10
New +$1.23K ﹤0.01% 427

Other funds holding INSM

S&T Bank's INSM Position: Q2 2026 in Review

S&T Bank increased its Insmed (INSM) stake by 12% in Q2 2026, buying an estimated $484 and bringing the position to 37 shares worth $3.94K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

S&T Bank first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.4K in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • S&T Bank held 37 shares of Insmed worth $3.94K as of Q2 2026.
  • S&T Bank bought 4 Insmed shares in Q2 2026, an estimated $484.
  • Insmed made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #355 holding.
  • S&T Bank first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • S&T Bank's Insmed position peaked at $5.4K in Q1 2026.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.